Whether blood eosinophils (bEOS) in chronic obstructive pulmonary disease (COPD) are associated with disease progression is a topic of debate. We aimed to evaluate whether the differential white blood cell (WBC) count, symptoms and treatment may predict lung function decline and exacerbations in COPD patients.

Circulating eosinophil levels and lung function decline in stable chronic obstructive pulmonary disease: a retrospective longitudinal study

Ferrari, Marcello;Pizzini, Michela;Cazzoletti, Lucia;Ermon, Valentina;Spelta, Francesco;De Marchi, Sergio;Carbonare, Luca Giuseppe Dalle;Crisafulli, Ernesto
2022-01-01

Abstract

Whether blood eosinophils (bEOS) in chronic obstructive pulmonary disease (COPD) are associated with disease progression is a topic of debate. We aimed to evaluate whether the differential white blood cell (WBC) count, symptoms and treatment may predict lung function decline and exacerbations in COPD patients.
2022
DPOC; Eosinófilos no sangue; Declínio de VEF1; Exacerbações; Biomarcadores
COPD; Blood eosinophils; FEV1 decline; Exacerbations; Biomarkers
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1080429
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact